{
  "document": {
    "acknowledgments": [
      {
        "summary": "Cleveland Clinic reported these vulnerabilities to Philips."
      }
    ],
    "category": "csaf_security_advisory",
    "csaf_version": "2.0",
    "distribution": {
      "text": "Disclosure is not limited",
      "tlp": {
        "label": "WHITE",
        "url": "https://us-cert.cisa.gov/tlp/"
      }
    },
    "lang": "en-US",
    "notes": [
      {
        "category": "legal_disclaimer",
        "text": "All information products included in https://us-cert.cisa.gov/ics are provided \"as is\" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.",
        "title": "Legal Notice"
      },
      {
        "category": "summary",
        "text": "Successful exploitation of these vulnerabilities could allow an attacker access to administrative controls and system configurations, which could allow changes to system configuration items causing patient data to be sent to a remote destination.",
        "title": "Risk evaluation"
      },
      {
        "category": "other",
        "text": "CRITICAL INFRASTRUCTURE SECTORS: Healthcare and Public Health",
        "title": "Critical infrastructure sectors"
      },
      {
        "category": "other",
        "text": "COUNTRIES/AREAS DEPLOYED: Worldwide",
        "title": "Countries/areas deployed"
      },
      {
        "category": "other",
        "text": "COMPANY HEADQUARTERS LOCATION: Netherlands",
        "title": "Company headquarters location"
      },
      {
        "category": "general",
        "text": "CISA recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities. Specifically, users should:",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.\nCISA also provides a section for control systems security recommended practices on the ICS webpage on\u00a0us-cert.gov. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on us-cert.gov in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.\nOrganizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.",
        "title": "Recommended Practices"
      }
    ],
    "publisher": {
      "category": "coordinator",
      "contact_details": "Email: CISAservicedesk@cisa.dhs.gov;\n Toll Free: 1-888-282-0870",
      "name": "CISA",
      "namespace": "https://www.cisa.gov/"
    },
    "references": [
      {
        "category": "self",
        "summary": "ICS Advisory ICSMA-20-233-01 - Web Scraped Version",
        "url": "https://us-cert.cisa.gov/ics/advisories/icsma-20-233-01"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.fda.gov/MedicalDevices/DigitalHealth/ucm373213.htm"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.us-cert.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.us-cert.gov/ics/tips/ICS-TIP-12-146-01B"
      }
    ],
    "title": "Philips SureSigns VS4",
    "tracking": {
      "current_release_date": "2022-10-10T21:50:15.745064+00:00",
      "generator": {
        "engine": {
          "name": "CISA CSAF Generator",
          "version": "1.0.0"
        }
      },
      "id": "ICSMA-20-233-01",
      "initial_release_date": "2020-08-20T00:00:00+00:00",
      "revision_history": [
        {
          "date": "2022-10-10T21:50:15.745064+00:00",
          "legacy_version": "Update A",
          "number": "1",
          "summary": "Publication Date"
        }
      ],
      "status": "final",
      "version": "1"
    }
  },
  "product_tree": {
    "branches": [
      {
        "branches": [
          {
            "branches": [
              {
                "category": "product_version_range",
                "name": "< S4 | A.07.107",
                "product": {
                  "name": "SureSigns - < S4 | A.07.107",
                  "product_id": "CSAFPID-0001"
                }
              }
            ],
            "category": "product_name",
            "name": "SureSigns"
          }
        ],
        "category": "vendor",
        "name": "Philips"
      }
    ]
  },
  "vulnerabilities": [
    {
      "cve": "CVE-2020-16237",
      "cwe": {
        "id": "CWE-20",
        "name": "Improper Input Validation"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The product receives input or data, but it does not validate or incorrectly validates that the input has the properties required to process the data safely and correctly.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-16237"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:P/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "As a mitigation to these vulnerabilities, Philips recommends users change all system passwords on the SureSigns VS4 with unique passwords for each device and secure the device when not in use to prevent unauthorized access, as referenced in the Installation and Configuration Guide available on Incenter. Philips also recommends users consider replacing the SureSigns VS4 device with a newer technology.\nUsers with questions regarding specific SureSigns VS4 patient monitor installations and upgrade options should contact Philips service support or regional service support or call 1-800-722-9377.\nPlease see the Philips advisory for vulnerabilities discussed in this disclosure, and visit the Philips product security website for the latest security information for Philips products.",
          "product_ids": [
            "CSAFPID-0001"
          ],
          "url": "https://www.philips.com/productsecurity"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 2.1,
            "baseSeverity": "LOW",
            "vectorString": "CVSS:3.0/AV:P/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001"
          ]
        }
      ]
    }
  ]
}